Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0001127602-24-010515 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-18 | 2024-03-14 | CYTK | Blum Robert I | Pres, CEO, Dir | A - Grant | $0.00 | +61.5K | 461.2K | +15% | $0 |
| DM | 2024-03-18 | 2024-03-14 | CYTK | Blum Robert I | Pres, CEO, Dir | A - Grant | $0.00 | +71.0K | 69.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-14 | A | A | 61,490 | $0.00 | 461,221 | D | — | — | |
| 2 | Derivative | Incentive Stock Option (Right to Buy) | 2024-03-14 | A | A | 1,568 | $0.00 | 1,568 | D | $63.75 · 2024-04-15 to 2034-03-14 | 1,568 Common Stock | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-03-14 | A | A | 69,464 | $0.00 | 69,464 | D | $63.75 · 2024-04-15 to 2034-03-14 | 69,464 Common Stock |